BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8282367)

  • 1. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
    Kuchel OG; Shigetomi S
    Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic abnormalities in borderline essential hypertensive patients.
    Shigetomi S; Buu NT; Kuchel O
    Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
    Kuchel O; Shigetomi S
    Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine deficiency--its potential contribution to chronic renal failure complicating hypertension.
    Kuchel O; Shigetomi S
    Hypertens Res; 1995 Jun; 18 Suppl 1():S183-5. PubMed ID: 8529056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
    Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
    Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
    Kuchel O
    Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart failure, aging, and renal synthesis of dopamine.
    Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
    Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
    Ferreira A; Bettencourt P; Pimenta J; Friões F; Pestana M; Soares-da-Silva P; Cerqueira-Gomes M
    Am Heart J; 2002 Mar; 143(3):391-7. PubMed ID: 11868042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sodium intake increases the urinary excretion of L-3,4-dihydroxyphenylalanine but fails to alter the urinary excretion of dopamine and amine metabolites in Wistar rats.
    Vieira-Coelho MA; Pestana M; Soares-da-Silva P
    Gen Pharmacol; 1996 Dec; 27(8):1421-7. PubMed ID: 9304419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of renal dopaminergic system activity during cyclosporine A administration in the rat.
    Pestana M; Vieira-Coelho MA; Pinto-do-O PC; Fernandes MH; Soares-da-Silva P
    Br J Pharmacol; 1995 Aug; 115(8):1349-58. PubMed ID: 8564191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dopaminergic mechanisms in renal parenchymal diseases and hypertension.
    Pestana M; Jardim H; Correia F; Vieira-Coelho MA; Soares-da-Silva P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():53-9. PubMed ID: 11369822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of urinary dopamine from plasma dihydroxyphenylalanine in humans.
    Wolfovitz E; Grossman E; Folio CJ; Keiser HR; Kopin IJ; Goldstein DS
    Clin Sci (Lond); 1993 May; 84(5):549-57. PubMed ID: 8504632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An increase in renal dopamine does not stimulate natriuresis after fava bean ingestion.
    Garland EM; Cesar TS; Lonce S; Ferguson MC; Robertson D
    Am J Clin Nutr; 2013 May; 97(5):1144-50. PubMed ID: 23553159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dopaminergic system in nephrotic syndrome and after remission.
    Pestana M; Jardim H; Afonso C; Serrão P; Santos N; Guerra L; Soares-da-Silva P
    Nephrol Dial Transplant; 1998 Oct; 13(10):2559-62. PubMed ID: 9794559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucocorticoids on renal dopamine production.
    Aguirre JA; Ibarra FR; Barontini M; Arrizurieta EE; Armando I
    Eur J Pharmacol; 1999 Apr; 370(3):271-8. PubMed ID: 10334502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension.
    Gill JR; Grossman E; Goldstein DS
    Hypertension; 1991 Nov; 18(5):614-21. PubMed ID: 1937664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal metabolism and effects of the glutamyl derivatives of L-dopa and 5-hydroxytryptophan in man.
    Li Kam Wa TC; Freestone S; Samson RR; Johnston NR; Lee MR
    Clin Sci (Lond); 1996 Aug; 91(2):177-85. PubMed ID: 8795441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans.
    Goldstein DS; Stull R; Eisenhofer G; Gill JR
    Clin Sci (Lond); 1989 May; 76(5):517-22. PubMed ID: 2498027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.